Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines

被引：0
|
作者：
Cocco, D. [1 ]
Ferro, E. G. [2 ]
Ricci, S. [1 ]
Deidda, M. [1 ]
Noto, A. [1 ]
Madeddu, C. [1 ]
Atzori, F. [1 ]
Scarlozzi, M. [1 ]
Mercuro, G. [1 ]
Dessalvi, C. Cadeddu [1 ]
机构：
[1] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3289 / 3289
页数：1
相关论文
共 50 条
  • [21] Prospective evaluation of echocardiography and serum biomarkers as predictors of cardiotoxicity in patients with breast cancer treated with anthracyclines, taxanes, with/without trastuzumab
    Solar Lopez, Jorge
    De Las Penas, Ramon
    De Avila, Leticia
    De Julian, Maria
    Amal, Maria
    Martinez-De Duenas, Eduardo
    Olmos, Santiago
    Lopez-Rodriguez, Angela
    Munarriz, Javier
    Peset, Ana
    Cortell, Alejandro
    Rodriguez, Candela
    Solloso, Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] RISK OF EARLY AND LATE CARDIOTOXICITY IN DOXORUBICIN-TREATED BREAST-CANCER PATIENTS
    BUZDAR, A
    SMITH, T
    MARCUS, C
    BLUMENSCHEIN, G
    BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (03) : 320 - 320
  • [23] Cardiac troponin T for early detection of cardiotoxicity in breast cancer patients treated with epirubicin
    Erdim, Refik
    Celiker, Aydin
    Gemici, Goekmen
    Tokay, Sena
    Uelfer, Goezde
    Dede, Fuat
    Turhal, Serdar
    Oktay, Ahmet
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2009, 4 (03): : 327 - 330
  • [24] Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study
    De Sanctis, V
    Alfo, M.
    Vitiello, C.
    Vullo, G.
    Facondo, G.
    Marinelli, L.
    Burocchi, S.
    Gallo, G.
    Valeriani, M.
    Campanella, B.
    Scalabrino, G.
    Russo, I
    Salerno, G.
    Cardelli, P.
    Osti, M. F.
    De Biase, L.
    CLINICAL BREAST CANCER, 2021, 21 (03) : E141 - E149
  • [25] Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
    Bertorello, Nicoletta
    Luksch, Roberto
    Bisogno, Gianni
    Haupt, Riccardo
    Spallarossa, Paolo
    Cenna, Rosita
    Fagioli, Franca
    PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [26] Changes in Plasma Hemopexin Are Inversely Associated With Myocardial Strain in Breast Cancer Patients Treated With Anthracyclines
    Asnani, Aarti
    Ngo, Debby
    Yang, Qiong
    Benson, Mark
    Sinha, Sumita
    Shen, Dongxiao
    Sebag, Igal
    Plana, Juan C.
    Scherrer-Crosbie, Marielle
    Gerszten, Robert E.
    CIRCULATION, 2019, 140
  • [27] Short-term anthracyclines-induced cardiotoxicity in breast cancer patients.
    Saidi, Mohammed Alaeddine
    Ghomari, Soumeyya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18703 - E18703
  • [28] BIOMARKERS AND STRAIN ECHOCARDIOGRAPHY FOR THE DETECTION OF SUBCLINICAL CARDIOTOXICITY IN BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINES
    Bhagat, Aditi A.
    Kalogeropoulos, Andreas P.
    Kort, Smadar
    Skopicki, Hal A.
    Butler, Javed
    Bloom, Michelle Weisfelner
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2400 - 2400
  • [29] Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines
    Bhagat, Aditi A.
    Kalogeropoulos, Andreas P.
    Baer, Lea
    Lacey, Matthew
    Kort, Smadar
    Skopicki, Hal A.
    Butler, Javed
    Bloom, Michelle Weisfelner
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (12):
  • [30] Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer
    Guenancia, Charles
    Ladoire, Sylvain
    Ghiringelli, Francois
    Rochette, Luc
    Vergely, Catherine
    Cottin, Yves
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2017, 110 (02) : 69 - 71
12345